Cannabis stocks are starting the week on cautious footing Sunday, October 25, 2026, as markets process last week’s flurry of Q3 2026 earnings reports and await fresh catalysts heading into the final stretch of Q4. With multistate operators (MSOs) having largely wrapped their earnings season, attention is shifting toward balance-sheet strength, cash-flow trajectories, and what the holiday quarter might hold for dispensary traffic across adult-use and medical states.
The broader cannabis sector remains under moderate pressure as investors digest mixed Q3 results. Curaleaf (CURLF) and Verano Holdings (VRNOF) both delivered earnings last week that beat analyst revenue estimates but came in light on adjusted EBITDA margins — a pattern the Street has grown increasingly impatient with. Meanwhile, Trulieve Cannabis (TCNNF) offered one of the stronger performances in the cohort, leaning on its dominant Florida retail network even as adult-use conversion timelines in the Sunshine State remain uncertain.
Top Movers to Watch This Week
With earnings season winding down, price discovery will be the dominant theme this week. Here are the names and catalysts worth tracking on your watchlist:
- TCNNF (Trulieve): After Friday’s post-earnings digestion, watch for analyst note updates Monday. Any upward revision to Q4 guidance language around Florida dispensary productivity could be a near-term catalyst.
- CURLF (Curaleaf): The company’s European operations remain a wildcard. Any news out of Germany’s maturing adult-use rollout could move the stock meaningfully.
- GTBIF (Green Thumb Industries): GTI continues to trade at a premium to peers on the strength of its RISE retail brand and Illinois market share. Q4 pre-announcement risk is low; this one is a relative safety play in the space.
- OGI (Organigram): The Canadian LP is benefiting from its BAT partnership and new product innovation. Watch for any investor day or product launch announcements.
- TLRY (Tilray Brands): Tilray’s diversification into beer and beverages continues to be both a story and a distraction. Sentiment is mixed heading into the week.
Sector Sentiment: Cautious but Not Bearish
The cannabis sector’s performance over the past week reflects a market in a “show me” posture. Investors want to see operating leverage translate into real free cash flow — not just EBITDA adjustments that paper over capex and working capital burn. That said, the underlying consumer demand story remains intact. Dispensary same-store sales trends, while uneven, are not deteriorating at alarming rates in the most mature adult-use states like Colorado, Michigan, and Illinois.
The macro overlay matters too. Interest rate expectations continue to weigh on cannabis equities — these are capital-intensive businesses with debt loads that become more expensive to refinance in a higher-for-longer rate environment. Any pivot signals from the Fed, or softer-than-expected inflation data this week, could provide a short-term tailwind for the entire small-cap and speculative growth space in which cannabis equities trade.
Eyes on the Tracker: Which Names Have Momentum?
If you want a real-time view of price action and relative strength across cannabis stocks, our cannabis stock tracker is updated throughout the trading week. Keep an eye on volume spikes relative to 30-day averages — these are often the first signal of institutional positioning changes, whether for or against a name.
Notably, short interest across several MSOs has ticked higher in recent weeks. That creates the setup for sharp short-covering rallies on positive surprise headlines — regulatory news, M&A rumors, or a state legalization vote update could trigger outsized moves in names with elevated short interest.
What’s on the Calendar This Week
Markets are closed Monday for the Columbus Day observance in some segments, though cannabis-specific catalysts don’t follow the traditional earnings calendar. Key things to monitor:
- State budget hearings in several non-legal states — watch for any cannabis tax revenue projection language that signals legislative intent for 2027.
- DEA administrative rulemaking docket — the comment period on Schedule III reclassification remains live; any procedural updates could move sentiment.
- Canadian LP Q3 reporting cycle — a few smaller LPs still have reports pending; expect Tilray and Cronos to generate headlines around their U.S.-expansion narratives.
TL;DR
Cannabis stocks enter the week of October 25 in consolidation mode after a heavy earnings week. MSO fundamentals are mixed but not deteriorating; GTI and TCNNF remain the relative-strength leaders. Macro rate dynamics and regulatory pipeline developments are the swing factors. Use the tracker to stay on top of intraday moves as the week develops.
— Sheeba M., Weedstock Market Desk